What is Dermatology Revenue Cycle Management?

Dermatology revenue cycle management is the process of optimizing collections across insurance and self-pay cosmetic services — including Mohs surgery coding, payer contract negotiation, and denial management — typically used by dermatology practices with 50%+ commercial payer mix where coding complexity creates above-average denial rates.

Dermatology Revenue Cycle

Revenue Cycle Fundamentals for Dermatology

What dermatology practice owners should understand about their revenue cycle: Mohs stage and section coding, the medical-cosmetic split, biologics buy-and-bill, and how each shapes collections.

Book a 30-minute call with Stan →

Walk through your revenue cycle numbers together. No obligation.

Dermatology Practices

Industry Context

Where Dermatology Practices Actually Lose Money

Revenue cycle complexity in dermatology comes from three places: Mohs surgery billing (which requires precise stage and section documentation), the medical-cosmetic split (which has implications for sales tax, payer billing, and patient collections), and biologics buy-and-bill (where a single missed J-code or wrong unit count can swing $5K to $15K on one claim). Most general medical billing setups handle the routine office visits and biopsies fine but lose money on the higher-complexity work where margins actually live.

A dermatology practice doing 30 Mohs cases per week with imprecise stage billing can leak $100K to $300K per year just on that line of service. Add in modifier 25 audits, biologics not billed correctly, cosmetic deposits that get refunded inappropriately, and pathology slides billed to the wrong entity, and the total revenue leakage on a $3M dermatology practice can easily exceed $250K per year that should have hit the bank.

Where the Money Leaks

Common Revenue Cycle Mistakes in Dermatology Practices

The specific patterns that cost dermatology practices the most every month.

01

Undercoding Mohs stages

Mohs procedures are billed with stage codes (17311/17312 cover face/scalp first stage + add-on; 17313/17314 cover trunk/extremity first stage + add-on — these are pairs, not four sequential stages) and section codes. When the operative note documents multiple additional stages but the claim only bills the first stage, the practice is leaving roughly $400 to $800 per case on the table. At Mohs volume, this adds up quickly.

02

Forgetting modifier 25 on same-day procedures

When a separately identifiable E/M is performed alongside a procedure, modifier 25 is required to bill both. Forgetting it means the visit gets bundled and the practice loses $80 to $150 per encounter. Adding it inappropriately triggers audits.

03

Not billing JW modifier for discarded biologics

Medicare and many commercial payers allow billing for the discarded portion of single-use biologic vials with the JW modifier. Practices not using this can leave $20K to $80K per year unbilled depending on their biologic volume.

04

Charging cosmetic patients full price after no-show

Cosmetic patient relationships are different from medical. Aggressive no-show fees collected over patient objection often result in chargebacks, online review damage, and lost lifetime value. A clear, signed cosmetic policy collected at booking solves this.

05

Billing pathology to the wrong entity

When pathology is billed in-house but processed by an outside lab, or vice versa, claims get rejected or audited. Setting up the correct relationship documentation between the practice and pathology entity is foundational and frequently mishandled.

The Numbers That Matter

Revenue Cycle Metrics for Dermatology Practices

Mohs Stage Billing Accuracy

Healthy range: 100 percent match on audit

Stages billed compared to stages documented in the operative note, per case.

Modifier 25 Utilization Rate

Visits billed with modifier 25 as a percentage of qualifying visits.

Biologic Reimbursement Margin

Net reimbursement per drug administration after acquisition cost and discard tracking.

Cosmetic Package Liability

Dollar value of unredeemed cosmetic package services on the books.

Days in AR

Healthy range: Under 35 days

Total accounts receivable divided by average daily revenue.

Net Collection Rate

Healthy range: 97 percent or higher

Total collections divided by allowed amounts after contractual adjustments.

Software & Vendors

Billing Systems and Clearinghouse Reality

Your EHR choice determines how much revenue cycle work can even be done. ModMed has reasonable Mohs documentation and billing workflows but requires customization to capture stage and section data correctly. Nextech and EZDERM have similar capabilities. The clearinghouse layer (TriZetto, Change Healthcare, Availity) handles claim submission and provides denial analytics that most practices never use.

Cosmetic billing platforms (Aesthetic Record, RepeatMD, PatientNow) handle deposits, package management, and loyalty programs but introduce reconciliation complexity. Pathology billing partners and biologic specialty pharmacies (Walgreens AllianceRx, CVS Specialty, Accredo) need to be set up with the correct billing relationships, as misconfiguration leads to claims being routed to the wrong entity and getting denied. Patient payment platforms (Cherry, CareCredit, Affirm) are common for cosmetic financing and reduce package abandonment.

Common Questions About Revenue Cycle Management for Dermatology Practices

Want to talk through your dermatology practice revenue cycle?

30 minutes with Stan. Walk through your numbers together. No obligation.

By state

Dermatology Practices accounting and CFO support, by state

State-level tax, payer, and regulatory context shapes what “good” looks like for dermatology practices practices. The pages below walk through each state's specifics.